Biocon gains on the bourses

03 Oct 2019 Evaluate

Biocon is currently trading at Rs. 223.30, up by 1.15 points or 0.52% from its previous closing of Rs. 222.15 on the BSE.

The scrip opened at Rs. 222.50 and has touched a high and low of Rs. 224.10 and Rs. 221.90 respectively. So far 3759 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 344.93 on 03-Oct-2018 and a 52 week low of Rs. 211.30 on 20-Aug-2019.

Last one week high and low of the scrip stood at Rs. 228.95 and Rs. 212.40 respectively. The current market cap of the company is Rs. 26658.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 20.72% and 18.61% respectively.

Biocon and Mylan N.V. have launched Semglee (insulin glargine solution for injection 100 IU/mL in a 3mL pre-filled pen), the first insulin glargine biosimilar in Australia available on the Pharmaceutical Benefits Scheme (PBS).

Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar levels of those with diabetes. It is indicated for the treatment of type 1 diabetes mellitus in adults, adolescents and children aged six years and above and type 2 diabetes mellitus in adults.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

378.95 -4.60 (-1.20%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×